Patent details

EP3723801 Title: TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH A S1P MODULATOR

Basic Information

Publication number:
EP3723801
PCT Application Number:
US2018065544
Type:
European Patent Granted for LU
Legal Status:
Unitary Effect Registered
Application number:
EP188306096
PCT Publication Number:
WO2019118778
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH A S1P MODULATOR
French Title of Invention:
TRAITEMENT D'UNE MALADIE INFLAMMATOIRE À L'AIDE D'UN DISPOSITIF INGESTIBLE DE LIBÉRATION D'UN MODULATEUR IMMUNITAIRE
German Title of Invention:
BEHANDLUNG VON ENTZÜNDLICHER KRANKHEIT MIT FREISTEHENDER VORRICHTUNG, UM DEN IMMUNE-MODULATOR ZU FREIEN
SPC Number:

Unitary Effect

Unitary Effect Requested:
Yes
Unitary Effect Request Filing Date:
12/06/2023
Link to UPP Register:
European Patent Register
Unitary Effect Request Withdrawal Date:
Unitary Effect Status:
Unitary Effect Registered
Unitary Effect Acceptance Decision Date:
12/07/2023
Unitary Effect Rejection Decision Date:
Unitary Effect Date:
07/06/2023
Unitary Effect Registration Date:
12/07/2023
Unitary Effect Re-establishment of rights Filing Date:
Unitary Effect Re-establishment of rights EPO Decision :
Unitary Effect Re-establishment of rights EPO Decision Date:
Explanatory Text UE:
Safety Net Request Date:
Safety Net Decision Date:
Safety Net Decision Outcome:
SPC Number:

Dates

Filing date:
13/12/2018
Grant date:
07/06/2023
EP Publication Date:
21/10/2020
PCT Publication Date:
20/06/2019
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/06/2023
EP B1 Publication Date:
07/06/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
13/12/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
31/05/2023
 
 

Name:
Biora Therapeutics, Inc.
Address:
4330 La Jolla Village Drive, Suite 200, San Diego, CA 92122, United States (US)

Inventor

1

Name:
JONES, Mitchell Lawrence
Address:
United States (US)

2

Name:
SINGH, Sharat
Address:
United States (US)

3

Name:
WAHL, Christopher Loren
Address:
United States (US)

4

Name:
STYLLI, Harry
Address:
United States (US)

5

Name:
PERERA, Aruna
Address:
United States (US)

6

Name:
HOWE, Kevin David
Address:
United Kingdom (GB)

Priority

1

Priority Number:
201762599000 P
Priority Date:
14/12/2017
Priority Country:
United States (US)

2

Priority Number:
201862687697 P
Priority Date:
20/06/2018
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/48; A61K 31/136; A61K 31/137; A61K 31/397; A61K 31/4196; A61K 31/428; A61K 31/436; A61K 31/519; A61K 31/606; A61K 38/08; A61K 31/4245; A61K 31/40; A61K 39/00; A61K 39/395; A61K 38/13; C07K 16/24; A61K 9/00; C07K 16/28;

Publication

European Patent Bulletin

1

Issue number:
202323
Publication date:
07/06/2023
Description:
Grant (B1)

2

Issue number:
202329
Publication date:
19/07/2023
Description:
Unitary Effect Request Receipt

3

Issue number:
202333
Publication date:
16/08/2023
Description:
Unitary Effect Request Acceptance

4

Issue number:
202340
Publication date:
04/10/2023
Description:
Document reprinted after correction (B8, B9)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages